Vikas Sinha
CIK 1337845 · Chief Financial Officer · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$27.39M
Companies
3
Total Filings
128
Lifetime Open-Market Net
-$4.66M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SRRK | Chief Financial Officer | 619,856 | $44.18 | $27.39M | -$1.23M | 5 | 2026-04-20 |
| Verona Pharma plc (VRNA) Delisted | Director | 0 | $106.91 | $0 | -$3.18M | 12 | 2025-10-08 |
| Kalaris Therapeutics, Inc. (ALVR) Delisted | See Remarks | 774,118 | $9.81 | $7.59M | -$246.5K | 40 | 2025-02-24 |
Recent Filings · Page 5 of 13
128 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-23 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −6,537 | -$33.3K | EDGAR |
| 2022-10-26 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −1,449 | -$13.6K | EDGAR |
| 2022-10-24 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −1,449 | -$13.6K | EDGAR |
| 2022-08-17 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2022-08-01 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +3,253,796 | $15.00M | EDGAR |
| 2022-07-21 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −1,432 | -$7.5K | EDGAR |
| 2022-07-06 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +29,400 | $0 | EDGAR |
| 2022-04-29 | Verona Pharma plc (VRNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-22 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Sell (S) | −1,162 | -$7.8K | EDGAR |
| 2022-04-04 | Kalaris Therapeutics, Inc. (ALVR) Delisted | Grant (A) | +48,838 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.